SGRY (Surgery Partners, Inc.) Stock Financials & Earnings | Market Cap Arena

SGRY (Surgery Partners, Inc.) Stock Financials & Earnings | Market Cap Arena

SGRYSurgery Partners, Inc.

Mkt Cap$2B

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Revenue (TTM)$3.3B

Net Income (TTM)-$78M

EPS (TTM)-$0.61

Free Cash Flow (TTM)$196M

Gross Margin23.1%

Op. Margin11.8%

Net Margin-2.4%

FCF Margin5.9%

P/S Ratio (TTM)0.5x

P/E Ratio (TTM)—

YoY Rev Growth+6.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$666M	$134M	$46M
Q2 23	$668M	$154M	$98M
Q3 23	$674M	$166M	$83M
Q4 23	$735M	$194M	$101M
Q1 24	$717M	$155M	$76M
Q2 24	$762M	$179M	$85M
Q3 24	$770M	$178M	$61M
Q4 24	$864M	$234M	$127M
Q1 25	$776M	$162M	$62M
Q2 25	$826M	$196M	$112M
Q3 25	$822M	$195M	$106M
Q4 25	$885M	$212M	$110M

Valuation

Quarter	P/S	P/E
Q1 23	0.7x	—
Q2 23	0.7x	—
Q3 23	0.6x	—
Q4 23	0.6x	—
Q1 24	0.6x	2912.6x
Q2 24	0.6x	—
Q3 24	0.6x	—
Q4 24	0.6x	—
Q1 25	0.6x	—
Q2 25	0.5x	—
Q3 25	0.5x	—
Q4 25	0.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$75M	$50M
Q2 23	$52M	$26M
Q3 23	$105M	$86M
Q4 23	$63M	$43M
Q1 24	$41M	$20M
Q2 24	$83M	$56M
Q3 24	$65M	$45M
Q4 24	$111M	$89M
Q1 25	$6M	-$17M
Q2 25	$81M	$58M
Q3 25	$84M	$64M
Q4 25	$103M	$91M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$24M
Q2 23	$26M
Q3 23	$19M
Q4 23	$20M
Q1 24	$21M
Q2 24	$27M
Q3 24	$20M
Q4 24	$22M
Q1 25	$23M
Q2 25	$23M
Q3 25	$20M
Q4 25	$13M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+11.7%	+25.0%
Q2 23	+8.5%	+5.8%
Q3 23	+8.6%	+8.2%
Q4 23	+4.0%	+3.4%
Q1 24	+7.7%	+3.5%
Q2 24	+14.2%	+18.8%
Q3 24	+14.3%	+19.9%
Q4 24	+17.5%	+16.3%
Q1 25	+8.2%	+11.3%
Q2 25	+8.4%	+5.5%
Q3 25	+6.6%	+0.9%
Q4 25	+2.4%	+5.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$4M	0.6%
Q2 23	$5M	0.7%
Q3 23	$0	0.0%
Q4 23	$5M	0.6%
Q1 24	$5M	0.7%
Q2 24	$0	0.0%
Q3 24	$7M	0.9%
Q4 24	$6M	0.7%
Q1 25	$8M	1.0%
Q2 25	$0	0.0%
Q3 25	$3M	0.3%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A
Q1 23	$32M
Q2 23	$31M
Q3 23	$37M
Q4 23	$21M
Q1 24	$33M
Q2 24	$40M
Q3 24	$29M
Q4 24	$36M
Q1 25	$36M
Q2 25	$36M
Q3 25	$324M
Q4 25	$127M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$246M	$0	$246M
Q2 23	$177M	$0	$177M
Q3 23	$236M	$0	$236M
Q4 23	$196M	$0	$196M
Q1 24	$185M	$0	$185M
Q2 24	$214M	$0	$214M
Q3 24	$222M	$0	$222M
Q4 24	$270M	$0	$270M
Q1 25	$229M	$0	$229M
Q2 25	$250M	$0	$250M
Q3 25	$203M	$0	$203M
Q4 25	$240M	$0	$240M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	125M	+22.9%
Q2 23	127M	+1.7%
Q3 23	126M	-1.3%
Q4 23	126M	+0.0%
Q1 24	126M	+0.2%
Q2 24	126M	+0.1%
Q3 24	126M	+0.0%
Q4 24	126M	+0.0%
Q1 25	127M	+0.3%
Q2 25	127M	+0.3%
Q3 25	127M	-0.0%
Q4 25	127M	+0.2%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	—	—
FY 15	$188K	5K
FY 16	$191K	6K
FY 17	$127K	11K
FY 18	$161K	11K
FY 19	$191K	10K
FY 20	$172K	11K
FY 21	$204K	11K
FY 22	$208K	12K
FY 23	$203K	14K
FY 24	$208K	15K
FY 25	$207K	16K